Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Insiders Trading CMTL, ANDS, CRI, AAPL
By Jonathan Moreland
Oct 25, 2011 9:29 AM EDT
INVESTING
7 Stocks Hitting New 52-Week Highs
By Stockpickr Staff
Oct 17, 2011 1:32 PM EDT
STOCKS
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
By Adam Feuerstein
Oct 17, 2011 11:55 AM EDT
STOCKS
Roche-Anadys Hookup Could Spark More Hep C Acquisitions
By Adam Feuerstein
Oct 17, 2011 9:16 AM EDT
STOCKS
Anadys To Be Bought by Roche for $230M
By Joseph Woelfel
Oct 17, 2011 6:08 AM EDT
STOCKS
Hep C Drug Updates: Vertex and Anadys
By Adam Feuerstein
Oct 13, 2011 11:01 AM EDT
STOCKS
Achillion CEO Needs to Deliver on Deal Talk
By Adam Feuerstein
Sep 7, 2011 1:04 PM EDT
STOCKS
Insiders Trading HAIN, APKT, ANDS, DISH
By Jonathan Moreland
Jan 4, 2011 9:24 AM EST
STOCKS
Insiders Trading ANDS, AAN, KRA, LAMR
By Jonathan Moreland
Dec 30, 2010 9:49 AM EST
STOCKS
Insiders Trading SCCO, QRE, AAN, ANDS
By Jonathan Moreland
Dec 28, 2010 4:15 PM EST
STOCKS
Insiders Trading ITW, CEVA, TAYC and ANDS
By Jonathan Moreland
Oct 25, 2010 9:00 AM EDT
STOCKS
Anadys' Stock Sale Doesn't Just Dilute
By Michael Baron
Oct 15, 2010 4:57 PM EDT
STOCKS
Biotech Stock Mailbag: Hep C Stocks to Watch
By Adam Feuerstein
Sep 10, 2010 7:00 AM EDT
OPINION
Top 10 Buy-Rated Stocks Under $5
By Robert Holmes
Jun 3, 2010 7:00 AM EDT
INVESTING
AEterna Zentaris, Akorn: Midday Volume Plays
By Robert Holmes
Apr 15, 2010 11:34 AM EDT
STOCKS
Sequenom, Delta Petroleum: Early Volume Plays
By Robert Holmes
Dec 17, 2009 8:45 AM EST
STOCKS
Biotech Calendar: Key Dates and Events
By Adam Feuerstein
Sep 30, 2009 9:55 AM EDT
STOCKS
Biotech Mailbag: Biocryst, Anadys, Allos, Amag
By Adam Feuerstein
Aug 21, 2009 7:00 AM EDT
STOCKS
Biotech Stock Mailbag: Chelsea Therapeutics
By Adam Feuerstein
Jul 10, 2009 8:00 AM EDT
STOCKS
Anadys Financing Tempers Hope for Hep C Deal
By Adam Feuerstein
Jun 4, 2009 10:29 AM EDT
STOCKS
Hepatitis C Updates From EASL Liver Confab
By Adam Feuerstein
Apr 27, 2009 9:43 AM EDT
STOCKS
Anadys Stock Falls on Hep C Data
By Adam Feuerstein
Apr 23, 2009 12:00 PM EDT
STOCKS
New Vertex CEO: Hep C Trials on Track
By Adam Feuerstein
Apr 16, 2009 4:16 PM EDT
STOCKS
Anadys Tries to Tempt Suitors With Hep C Data
By Adam Feuerstein
Apr 6, 2009 1:23 PM EDT
STOCKS
Vertex Hep C Drug Improves Cure Rate in Study
By Adam Feuerstein
Mar 19, 2009 10:31 AM EDT
